Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma.
Journal: Cancers
Published: October 20, 2025
Long-term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma.
Journal: BJUI compass
Published: September 01, 2025
Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center Experience.
Journal: Clinical genitourinary cancer
Published: July 15, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma.
Journal: European urology oncology
Published: June 05, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma.
Journal: European urology
Published: May 18, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: May 02, 2025
Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases.
Journal: Urology practice
Published: March 14, 2025
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management Option.
Journal: Urology practice
Published: January 28, 2025
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 03, 2024
Last Updated: 09/26/2026